DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Munoz C, Adasme F, Alzate-Morales JH. et al.
Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations.
J Mol Graph Model 2012;
32: 39-48.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.